CARLSBAD, Calif., Nov. 12, 2025 /PRNewswire/ — Tyra Biosciences, Inc. (Nasdaq: TYRA), a clinical-stage biotechnology company focused on developing next-generation precision medicines that target large opportunities in Fibroblast Growth Factor Receptor (FGFR) biology, announced today that members of company management will participate in the following investor events: Jefferies London Healthcare ConferenceFormat: Hybrid presentation (slides &… Continue reading Tyra Biosciences Announces Participation at Upcoming Investor Events
Category: News Type
Armata Pharmaceuticals Announces Third Quarter 2025 Results and Provides Corporate Update
LOS ANGELES, Nov. 12, 2025 /PRNewswire/ — Armata Pharmaceuticals, Inc. (NYSE American: ARMP) (“Armata” or the “Company”), a clinical-stage biotechnology company focused on the development of high-purity, pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat bacterial infections, today announced financial results for its third quarter ended September 30, 2025, and provided a corporate update.… Continue reading Armata Pharmaceuticals Announces Third Quarter 2025 Results and Provides Corporate Update
Azenta Announces Fiscal 2025 Fourth Quarter and Full Year Conference Call and Webcast
BURLINGTON, Mass., Nov. 12, 2025 /PRNewswire/ — Azenta, Inc. (Nasdaq: AZTA) will announce fiscal fourth quarter and full year 2025 earnings which ended on September 30, 2025, on Friday, November 21, 2025, before the market opens. The Company will host a conference call and live webcast to discuss its financial results on the same day,… Continue reading Azenta Announces Fiscal 2025 Fourth Quarter and Full Year Conference Call and Webcast
Talphera Announces Third Quarter 2025 Financial Results and Provides Corporate Update
Closed $17 million first tranche financing led by a strategic investment from CorMedix, Inc. Cash and investments at September 30, 2025 were $21.3 million; combined with conditional future tranches of previous financings, expect sufficient cash through a potential PMA approval of Niyad in late 2026 5 of the 9 target profile clinical sites are now… Continue reading Talphera Announces Third Quarter 2025 Financial Results and Provides Corporate Update
Rollins, Inc. Announces Closing of Secondary Public Offering of Common Stock
ATLANTA, Nov. 12, 2025 /PRNewswire/ — Rollins, Inc. (NYSE: ROL) (“Rollins” or the “Company”) today announced the closing of the previously announced secondary public offering of 17,391,305shares of its common stock, which included 2,608,695 shares sold pursuant to the underwriters’ exercise in full of an option (the “Offering”), by LOR, Inc. and Rollins Holding Company, Inc., two… Continue reading Rollins, Inc. Announces Closing of Secondary Public Offering of Common Stock
First Brands’ founder regains access to funds as court rejects asset freeze
For individuals Discover all the plans currently available in your country For multiple readers Digital access for organisations. Includes exclusive features and content. Go to Source
Europe’s carmakers face ‘devastating’ chip crisis as Nexperia supply crunch continues
For individuals Discover all the plans currently available in your country For multiple readers Digital access for organisations. Includes exclusive features and content. Go to Source
German FAZ: These are the most popular electric cars in Germany010236
FAZ+BYD is catching up: These are the most popular electric cars in Germany12.11.2025, 3:09 p.m. Reading time: 6 min. Expand image descriptionFor the first time since the purchase bonus expired, every fifth new car in October is an electric car. The Skoda Elroq leads the rankings of new registrations for the first time, but BYD… Continue reading German FAZ: These are the most popular electric cars in Germany010236
German FAZ: Rich calls for an agenda 2030010238
The Federal Minister of Economics is calling for a new agenda to strengthen the economy in Germany. With the reforms of Agenda 2010, Germany once achieved a “new dynamic,” said Katherina Reiche on Monday, referring to the reform package of former Chancellor Gerhard Schröder (SPD). Now Germany is once again in a situation in which… Continue reading German FAZ: Rich calls for an agenda 2030010238
German FAZ: A solution is probably emerging in the Nexperia crime story010237
FAZ+Important for the auto industry: A solution is probably on the horizon in the crime involving Nexperia07.11.2025, 6:17 p.m. Reading time: 5 min. Expand image description There is a semiconductor company in the Netherlands that is systemically relevant to the German auto industry. Now it is in trouble because there is a dispute with China.… Continue reading German FAZ: A solution is probably emerging in the Nexperia crime story010237